CVS insider buying image
The table below summarizes the most recent CVS insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why CVS insider buys are important for investors to follow.
DateInsiderPriceAmount
1-23-2025
Insider Buy
Steven H. Nelson
EVP and President, Aetna
$53.70
CAGR »
$1,288.80
24 shares
10-23-2024
Insider Buy
Heidi B. Capozzi
EVP and Chief People Officer
$57.36
CAGR »
$4,588.60
80 shares
6-5-2025
Insider Buy
Guy P. Sansone
Director
$63.70
CAGR »
$100,009.00
1,570 shares
2-18-2025
Insider Buy
Michael F. Mahoney
Director
$66.70
CAGR »
$2,001,000.00
30,000 shares
5-2-2024
Insider Buy
Michael F. Mahoney
Director
$54.49
CAGR »
$500,293.81
9,181 shares
5-2-2024
Insider Buy
Edward J. Ludwig
Director
$53.88
CAGR »
$53,879.00
1,000 shares
11-3-2023
Insider Buy
Edward J. Ludwig
Director
$70.47
CAGR »
$140,930.00
2,000 shares
5-3-2023
Insider Buy
Karen S. Lynch
President and CEO
$69.75
CAGR »
$976,567.20
14,000 shares
2-10-2022
Insider Buy
Edward J. Ludwig
Director
$105.90
CAGR »
$105,904.40
1,000 shares
8-5-2021
Insider Buy
Edward J. Ludwig
Director
$79.55
CAGR »
$238,635.00
3,000 shares
2-17-2021
Insider Buy
Edward J. Ludwig
Director
$72.00
CAGR »
$216,000.00
3,000 shares
5-11-2020
Insider Buy
Alan Lotvin
EVP and President-CVS Caremark
$63.13
CAGR »
$315,675.00
5,000 shares
3-8-2019
Insider Buy
Edward J. Ludwig
Director
$52.80
CAGR »
$105,600.00
2,000 shares
3-8-2019
Insider Buy
David W. Dorman
Director
$52.71
CAGR »
$506,016.00
9,600 shares
3-11-2019
Insider Buy
C. David Brown II
Director
$53.18
CAGR »
$531,800.00
10,000 shares
3-11-2019
Insider Buy
Fernando Aguirre
Director
$53.59
CAGR »
$101,821.00
1,900 shares
3-1-2019
Insider Buy
Fernando Aguirre
Director
$58.29
CAGR »
$198,768.90
3,410 shares
3-1-2019
Insider Buy
Edward J. Ludwig
Director
$58.27
CAGR »
$233,080.00
4,000 shares
5-4-2018
Insider Buy
C. David Brown II
Director
$61.99
CAGR »
$619,900.00
10,000 shares
5-4-2018
Insider Buy
David W. Dorman
Director
$62.22
CAGR »
$1,511,868.24
24,300 shares
7-9-2012
Insider Buy
Stephen J. Gold
SVP & CIO
$47.29
CAGR »
$450,011.64
9,516 shares
2-13-2012
Insider Buy
Per GH Lofberg
EVP and President, Caremark
$42.99
CAGR »
$1,994,736.00
46,400 shares
5-23-2011
Insider Buy
Terrence Murray
Director
$35.52
CAGR »
$8,523.95
240 shares

Also See: Institutional Holders of CVS
Also See: SEC filings

CVS Performance Since Insider Purchase
Below we present the annualized performance delivered by CVS stock since 1-23-2025 (the date of the most recent insider purchase). The performance of the investment from the time CVS insider buying occurred is the ultimate test of whether insiders were right about CVS being a good buy.

Growth of $10,000.00
With Dividends Reinvested

Start date: 01/24/2025
End date: 04/13/2026
Start price/share: $54.55
End price/share: $78.09
Starting shares: 183.32
Ending shares: 190.25
Dividends reinvested/share: $2.66
Total return: 48.57%
Average Annual Total Return: 38.56%
Starting investment: $10,000.00
Ending investment: $14,856.13
Years: 1.21
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/24/2025
End date: 04/13/2026
Start price/share: $54.55
End price/share: $78.09
Dividends collected/share: $2.66
Total return: 48.03%
Average Annual Total Return: 38.15%
Starting investment: $10,000.00
Ending investment: $14,802.79
Years: 1.21

CVS Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent CVS insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding CVS